Jane Street
BIAF icon

Jane Street’s bioAffinity Technologies BIAF Stock Holding History

Jane Street’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.7K Buy
+1,786
New +$54.7K ﹤0.01% 11186
2022
Q4 		– Sell
-24
Closed -$32K – 9143
2022
Q3 		$32K Buy
+24
New +$45.4K ﹤0.01% 9068

Other funds holding BIAF

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jane Street's BIAF Position: Q2 2026 in Review

Jane Street opened a new position in bioAffinity Technologies (BIAF) in Q2 2026: 1,786 shares worth $21.7K. The stake represents ﹤0.01% of the portfolio and ranks #11186 among its holdings. This is a return to the name: Jane Street previously reported a position in BIAF as recently as Q3 2022.

Jane Street first reported a position in BIAF in Q3 2022 and has held it in 2 quarters since. The position peaked at $32K in Q3 2022. 19 funds tracked by Wall St. Rank hold BIAF as of Q2 2026.

  • Jane Street held 1,786 shares of bioAffinity Technologies worth $21.7K as of Q2 2026.
  • bioAffinity Technologies was a new Jane Street position in Q2 2026.
  • bioAffinity Technologies made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #11186 holding.
  • Jane Street first reported a position in bioAffinity Technologies in Q3 2022 and has held it in 2 quarters since.
  • Jane Street's bioAffinity Technologies position peaked at $32K in Q3 2022.
  • 19 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.